Enhertu 100mg Injection(Trastuzumab Deruxtecan (100mg))
Rs. 167,069.00
Add to wishlistDescription
Enhertu 100mg Injection is used to treat HER2-positive metastatic breast cancer and gastric cancer. These cancers have high levels of the protein called HER2, which promotes cancer cell growth. It binds to HER2 proteins and delivers chemotherapy directly to cancer cells, destroying them while sparing healthy cells.
A doctor or a nurse administers Enhertu 100mg Injection as an intravenous (IV) infusion, typically every three weeks. Sticking to this schedule is crucial to allow the medication to work effectively, as consistent dosing helps keep cancer cell growth in check. Make sure to attend all scheduled appointments and follow any additional advice from the doctor. Drink plenty of water, stay hydrated, and eat a balanced diet to help the body handle the treatment’s effects.
Common side effects of Enhertu 100mg Injection include nausea, fatigue, decreased appetite, and low blood cell counts, making a person more susceptible to infections. If you experience any of these side effects, consult your doctor. They can advise you on managing the side effects and making the treatment experience as smooth as possible.
While undergoing treatment with Enhertu 100mg Injection, avoid alcohol, as it may add strain to the liver, which is already working to process the drug. Patients should also exercise caution with activities that may lead to injury, given the increased risk of infections due to potentially lower white blood cell counts. Enhertu 100mg Injection is not suitable for everyone, particularly those with lung issues, as it has been linked to severe lung conditions like interstitial lung disease (ILD). Additionally, women who are pregnant, planning to become pregnant, or breastfeeding should not take Enhertu 100mg Injection, as it can harm the fetus or infant.
Reviews
There are no reviews yet.